Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer
Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer
Recruiting · NCT07534033 · Registry updated 2026-04-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer | A Multidisciplinary Team Assessment Determined That the Patient Was a Suitable Candidate for Radical Surgical Resection; AJCC is Classified as IB-IIIC; NSCLC Diagnosed by Histology or Cytology; Overall Lung Function is Adequate for the Planned Lung Resection | Recruiting | Phase 2 | 2026-04-16 | NCT07534033 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zhujiang Hospital | 82 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhu Jiang Hospital of Southern Medical University | Guangzhou | China | 1 |